Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Biotech Startup Investors in Austria in April 2025

Last updated: Apr 2025 A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotech startups based in Austria. We rank investors based on the number of investments they made in Biotech companies from Austria. We update this investor list every month.

Top 50 Biotech Startup Investors in Austria in April 2025

Investor	Biotech Austria investments
xista science ventures	10
xista science ventures	9
tecnet equity	6
SOSV	5
MIG Capital	5
austria Wirtschaftsservice (aws)	5
Arax Capital Partners	3
Schnidar Harald	3
R42 Group	2
bmp Ventures	2
APEX Ventures	2
Aescap Venture	2
FPS-Holding	2
Lansdowne Partners	2
TSVC	2
10x Founders	2
APEX Ventures	2
Longevitytech.fund	2
BackBone Ventures	2
Übermorgen Ventures	2
red-stars.com	2
aws Gründungsfonds	2
PUSH VC	2
Nina Capital	2
Synthesis Capital	1
Climentum Capital	1
Gamma Capital Partners	1
Polaris Partners	1
Sofinnova Partners	1
MCI Capital SA	1
Borregaard ASA	1
42CAP	1
FastVentures	1
HackCapital	1
SFG Steirische Wirtschaftsförderungsgesellschaft m.b.H	1
HBM Partners	1
Credit Agricole CIB	1
RKP InnoInvest	1
HCVC	1
ReGen Ventures	1
Clima Now	1
Die Wirtschaftskammer	1
ICL Planet Startup Hub	1
Santo Holding	1
Axilium Holding	1
Air Street Capital	1
Auxxo	1
Matthias Wilrich	1
Andera Partners	1
4SC	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Investment focus

Biotechnology, Medical, Medical Device
Seed, Pre-Seed, Series A
Austria, France, Slovenia

Portfolio highlights

Syntropic — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
HEPHAISTOS-Pharma — Hephaistos Pharma is a developing weapons firm. They provide services for oncology, immunotherapy, and cancer. An online inquiry form is available on the company's website.

Investment focus

Biotechnology, Medical, Software
Seed, Pre-Seed, Series A
Austria, Slovenia

Portfolio highlights

subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
VALANX Biotech — Protein conjugation. Specific, fast and cost effective.

tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.

Investment focus

Software, SaaS, Information Technology
Seed, Funding Round, Series A
Austria

Portfolio highlights

Sipfront — Sipfront helps telecom operators to deliver better services by automating 24/7 active monitoring and by providing a test framework to simulate customer calls at scale
Orderlion — Streamline your wholesale business with Orderlion's ordering app. Automate orders, boost sales, and enhance customer loyalty. Find out more!
VALANX Biotech — Protein conjugation. Specific, fast and cost effective.

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Investment focus

Biotechnology, Health Care, Software
Seed, Convertible Note, Pre-Seed
United States, India, United Kingdom

Portfolio highlights

MixRift — MIXRIFT - game developers specialized in Mixed Reality
unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Zusammen gestalten wir die Unternehmen von morgen.

Investment focus

Biotechnology, Health Care, Medical
Series A, Funding Round, Series B
Germany, France, Austria

Portfolio highlights

Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
Innatera — Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.

The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.

Investment focus

Software, Information Technology, Biotechnology
Seed, Grant, Pre-Seed
Austria, Belgium

Portfolio highlights

HD Immune — HD Immune develops an antibody to target the mutated protein and remove it from the body. HDI has a lead antibody mAB C6-17 which lowers mtHTT in the blood and organs.
Aitiologic — aitiologic is an Austrian precision medicine startup developing ai-powered solutions for early disease detection and targeted therapy.
revitalyze — revitalyze - AI Assistant for Construction

ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment

Investment focus

Biotechnology, Health Care, Medical
Seed, Funding Round
Austria

Portfolio highlights

AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
Calyxha Biotechnologies GmbH — A new perspective on inflammation

Entrepreneur, Angel Investor, Scientist and Inventor

Investment focus

mHealth, Software, Biopharma
Seed, Angel, Pre-Seed
Austria

Portfolio highlights

SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Investment focus

Biotechnology, Health Care, Information Technology
Seed, Funding Round, Pre-Seed
United Kingdom, United States, Austria

Portfolio highlights

Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Investment focus

Information Technology, Software, Manufacturing
Seed, Funding Round, Series A
Germany, United States, Austria

Portfolio highlights

Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
RAYDIAX — We are Raydiax.Interventional only.Our goal is to reinvent computer tomography that is focussed on treatment.
XenoPatch GmbH — First-ever portable device for pain management, seamlessly combines heat, cold and vibration treatment with an intuitive smartphone app.

APEX Ventures is a deep-tech and medical-focused venture capital firm.

Investment focus

Artificial Intelligence, Health Care, Software
Seed, Series A, Pre-Seed
Germany, United Kingdom, Austria

Portfolio highlights

GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.

The Aescap funds invest in highly innovative publicly traded biotech/life sciences companies. We're able to select the promising companies

Investment focus

Biotechnology, Pharmaceutical, Chemical
Series A, Series B, Funding Round
United Kingdom, Austria, Belgium

Portfolio highlights

Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja JÃ¤Ã¤ttela and Thomas Kirkegaard Jensen from the Danish Cancer Society (KrÃ¦ftens BekÃ¦mpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
Avantium — Build a sustainable future with Avantium. Leading the change in green chemistry and innovative solutions.
F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.

SPV

Investment focus

Biotechnology, Health Diagnostics
Seed
Austria

Portfolio highlights

Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.

Fundamental Equity Investing, since 1998

Investment focus

Biotechnology, Machine Learning, Finance
Funding Round, Series A, Series B
United Kingdom, Austria, United States

Portfolio highlights

Nattergal — Nattergal is a company with a mission to deliver nature recovery at scale, to provide vital benefits for society and sustainable financial returns.
G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
AMNIS Treasury Services — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Funding Round, Series A
United States, China, Canada

Portfolio highlights

Akool — Akool provides a generative AI platform that supercharges business with personalized premium quality visual content for marketing and advertisement.
Lumotive — Lumotive is a Seattle-based startup company developing high performance, solid-state lidar for autonomous systems in the automotive, UAV, robotics and related industries. The company's revolutionary beam-steering technology leverages Liquid Crystal Metasurfaces (or LCMs) implemented in mature semiconductor manufacturing processes to deliversmall, inexpensive 3D perception systems with unprecedented performance and reliability. For more information, visit us at www.lumotive.com.
Place Genomics Corporation — Bio Tech

Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Pre-Seed
Germany, United States, United Kingdom

Portfolio highlights

Floy — Floy develops AI-driven software that supports radiologists in detecting complex and hard-to-identify diseases. The collaboration of Floy-AI and radiologists ensures optimal patient outcomes by enabling the early detection and thus early treatment of diseases.One of Floy’s distinguishing features is our innovative incentive structure. We partnerwith radiology offices to jointly offer patients our AI as a “second opinion”. This unique approach motivates radiologists to embrace Floy-AI and encourages widespread adoption.Since its establishment in 2021, Floy secured €8.8 million in funding and rapidly expanded its presence with over 150 radiology locations to date. Floy’s overarching mission is to pioneer proactive medicine by providing exceptional AI-powered diagnostic experiences for health-conscious patients.
Landeed — Do you own your land? Download Landeed app to check real ownership of your property
qeen.ai — qeen.ai is a GenAI native platform that enables autonomous AI to e-commerce firms of all sizes.

APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.

Investment focus

Artificial Intelligence, Health Care, Software
Seed, Series A, Pre-Seed
Germany, United Kingdom, Austria

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.

Investing globally in technologies extending healthy lifespans

Investment focus

Biotechnology, Health Care, Personal Health
Seed, Convertible Note, Pre-Seed
United States, United Kingdom, The Netherlands

Portfolio highlights

Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.

BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.

Investment focus

Information Technology, Artificial Intelligence, Software
Seed, Pre-Seed, Funding Round
Switzerland, Germany, Israel

Portfolio highlights

Cloudsquid — is an an artificial intelligence based revenue orchestration company intended for companies with usage-based pricing models.
CROWN — CROWN is modernizing procurement negotiations through ethical eAuctions.
Exakt Health — Exakt Health is the physio app for sports injuries. The Exakt Health app guides users through self-diagnosis for frequent sports injuries and then creates an individualized rehabilitation plan.

We are an early stage VC for climate tech startups.

Investment focus

Software, Energy, Renewable Energy
Seed, Pre-Seed, Funding Round
Germany, Switzerland, Finland

Portfolio highlights

Marathon Fusion — The fuel cycle for fusion energy.
Companion.energy — Companion.energy provides energy management, forecasting and flexibility software to bridge the gap between energy procurement and operations.
Open Forest Protocol — With Open Forest Protocol (OFP), measure, report, verify and fund forestation projects with digital transparency

red-stars.com is an operative holding company that invests in and manages companies that provide mission-critical products and offerings to enable DIGITALIZATION and LIFE SCIENCES.

Investment focus

Software, Biotechnology, Telecommunications
Funding Round, Seed
Austria, Germany

Portfolio highlights

Txture — Txture is an end-to-end cloud transformation platform for planning transformations, migration management and cloud infrastructure optimization.
a:head bio — a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.

aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Funding Round
Austria, United States, Germany

Portfolio highlights

Tree.ly — Tree.ly enables forest owners to generate additional income. Companies can buy high-quality carbon credits.
Greenpass — Greenpass is a ClimateTech company providing the official greenpass for climate proof real estate. Build resilience and manage climate-proof assets and portfolios in line with ESG regulations while maximizing return on invest and value with ease.
HelloBello — HelloBello offers freshly cooked and cooled delivered human-grade food tailored to each dog’s nutritional needs. HelloBello is a PetTech company with a strong focus on the German speaking markets (for now). HelloBello’s personalized meals are free of any by-products and are portioned, packaged, and delivered directly to your door. By working with aspecialized veterinarian, HelloBello is able to derive each dog’s exact nutritional needs based on a proprietary algorithm. The recipes are made of natural sources like millet and seaweed, instead of heavy use of supplements, which makes it easier for the dog to absorb and get true nutritional benefits.Our credo in German is " ... Frisch. Individuell. Geliefert. - Frischfutter ist einfach besser ..."

| Investments that move industries

Investment focus

Software, Apps, Information Technology
Seed, Series A, Funding Round
Austria, Germany, United States

Portfolio highlights

Balun — Balun is a machine learning platform that forecasts electricity generation with unrivaled precision by analyzing multiple meteorological and energy market inputs, allowing renewable energy producers to optimize production, reduce penalties, and assure a stable, efficient grid.
Podero — Podero's aim is to create software that controls energy devices, such as batteries, electric cars, and heat pumps, in order to lower CO2 emissions, create new revenue streams for utilities, and lower consumer electricity bills.Podero's objective is to make it possible to coordinate the largest fleet of devices in the world by utilizingtrade algorithms, software automation, and machine learning forecasts to move energy use to the most economical and sustainable times.
enspired — enspired is a fully digital energy trading-as-a-service company. We drive the energy transition by enabling our clients to bring flexible assets to power spot markets and capture their full value with our AI-based trading services. Our team consists of leading algorithmic traders, data scientists and technology enthusiasts who firmly believe thatthe way power is traded will soon drastically change - in our world, there is no room for trading screens and traditional optimization. All trades get executed in a fully automated fashion using advanced AI algorithms that outperform the market and monetize our client's flexibility to the fullest while supporting grid stability. Our clients include leading utilities, operators of renewables and batteries or consumption assets across Europe.

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Investment focus

Health Care, Artificial Intelligence, Software
Seed, Pre-Seed, Series A
United States, United Kingdom, Austria

Portfolio highlights

Noah Labs — Noah Labs is a compant that creates AI-powered software solutions for medical care and research that help diagnose, manage illnesses, and guide interventions.
Sonar — Sonar is a scalable mental health platform for schools. We use a combination of AI and human connection to ensure every student is seen and supported. For educators, Sonar offers actionable insights to improve mental wellbeing, empower your staff, and boost student outcomes.
Lillian Care — Lillian is building a nationwide network of health facilities in Germany.

We are The Future Food Investors. Alternative Proteins Pioneers, we combine Smart Capital, Deep Expertise and Food Tech Startups!

Investment focus

Biotechnology, Food and Beverage, Organic Food
Seed, Funding Round, Series A
United States, Israel, Austria

Portfolio highlights

Triplebar — Triplebar provides sustainability, biotechnology, and synthetic biology research.
Savor — Savor makes delightfully rich foods without animals, farmland, fertilizers, hormones, or antibiotics.
Hyfé — Hyfé Foods is a biotech company producing ingredients by leveraging fungal fermentation to upcycle water byproducts from food manufacturers.

A Venture Capital firm investing into European early-stage tech companies attacking CO2 emissions

Investment focus

CleanTech, Clean Energy, Biotechnology
Seed, Series A, Series B
Sweden, Spain, Austria

Portfolio highlights

ecoLocked — ecoLocked is your partner to create a climate-positive built environment. We develop CO2-optimized recipes for concrete based on carbon-negative biochar admixes. Our admixes allow to store captured CO2 in buildings, reduce direct emissions from concrete production, and provide multiple functional benefits, such as improved thermal insulation.
Scale Energy — Reduce your energy cost without any investment
ZeroPoint Technologies — ZeroPoint Technologies AB was created in 2016 as a spinout from Chalmers University of Technology. The Intellectual Property Portfolio related to computer memory management was the acquired from the University and transferred into a new startup.The Technology, ideas and many of the people behind and with ZeroPoint comes from Professor PerStenströms research group, which is internationally recognized for excellence within high-performance Computing. Since its creation, ZeroPoint has attracted skilled people from industry, finance and the startup community and raised its’ first round of Venture Capital in 2016.

GCP Gamma Capital Partners is a private Venture Capital investment and Equity consulting firm established in 2002 (GCP Presentation 2020). We focus on dynamic technology and growth companies in Austria, Germany, Switzerland and CEE countries bordering Austria. We aim for value creation and value realization to generate superior returns for our investors and clients.

Investment focus

Mobile, iOS, Mobile Apps
Series A, Seed, Series C
Austria, Switzerland, United States

Portfolio highlights

Wikitude — Wikitude Augmented Reality empowers your iOS, Android & Smart Glasses apps with Image & Object Tracking, Instant tracking (SLAM), Geo AR, and more.
42matters AG — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
Organica Water — Organica Water is a global provider of innovative solutions for the treatment and recycling of wastewater. Over the past two decades Organica has developed a truly unique approach, enabling customers all over the world to build and operate space and energy efficient biological wastewater treatment plants (WWTPs) that blend harmoniously into urbanand residential population centers, ultimately lowering infrastructure costs and facilitating reuse and recycling of treated wastewater. Established in 1998, Organica began as a traditional wastewater design-build company focused exclusively on the Hungarian market. During the first nine years of its life the company built over 75 municipal, commercial, and industrial WWTPs using a variety of different technologies, while continually investing into R&D to futher develop its own IFAS-type solution for biological wastewater treatment. In 2007 Organica sold it's design-build business to focus exclusively on the commercialization of its own biological wastewater treatment solution on a global basis. Today, Organica is an international company operating on three different continents, and the world leader in Fixed-Bed Biofilm Activated Sludge (FBAS) technology,with more than 25 operating references all over the world, and nearly a dozen additional Organica-powered WWTPs currently under construction.

Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, Singapore, Ireland

Portfolio highlights

Candesant Biomedical — Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis. It offers a technology that is based on the principle that alkali metals in contact with water generate energy. The insight was that when the amounts of metal and water are controlled, the result is targeted delivery of energy exactly at the site of the water. Itsdevice is designed to target and inactivate the most active sweat glands.The company was founded in 2016 and is headquartered in San Francisco, California.
Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
Crossbow Therapeutics — Crossbow Therapeutics is a seed-stage, stealth-mode oncology startup company. The company develops antibody engineering for intracellular cancer targets.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

BetterOmics — The Omics AI Cloud
l`école — l'école AI is a computer vision-focused development platform. Its objective is to enable humans to use AI with purpose to change the future, beginning with a focus on speeding advances in life sciences using computer vision.
Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.

MCI Capital is a leading Digital Private Equity investor in CEE, based in Warsaw, Poland. MCI Capital seeks to invest in digital disruption, transformation and infrastructure within EU, with focus on CEE. Preferred sectors are SaaS, E-commerce, Marketplace, Fintech, Insurtech, Foodtech, Traveltech and Digital Infrastructure. MCI typically investsEUR 25-100 M in a single project, either in Buyout or Expansion stage. Historically, MCI Capital has also been involved in funds dedicated to Private Debt, Growth and Venture Capital areas – these funds do not conduct any new investments, instead they focus on building the value of assets and de-investing.MCI Capital is managed by the executive management team. The company is listed on the Warsaw Stock Exchange since February 2001 and is also a member of the Polish Private Equity Association.

Investment focus

E-Commerce, Software, Mobile
Series A, Funding Round, Seed
Poland, Germany, United Kingdom

Portfolio highlights

IdoSell —
Gett — Gett is a technology platform focused on corporate Ground Transportation Management (GTM), where spend is estimated to exceed $100 billion globally. https://gett.com/why We are the GTM category leader, serving over a quarter of the Fortune 500 companies.Gett’s cloud-based software organizes thousands of transportation providers(corporate fleet, ride-hailing, taxi, and limos) into one single platform. The technology helps save businesses time and money by managing all their ground transportation spend, and optimizes the entire employee experience from booking and riding to invoicing and analytics.We are building the first ground transportation grid available to customers worldwide, similar to telephony and internet grids, with aspirations to become the standard in corporate ground transportation, just as Zoom became the standard in corporate communication.Founded in 2010 and headquartered in London, Gett has raised more than $750M in funding to date, including more than $300M from the Volkswagen Group. They employ over 800 employees globally.
ANSWEAR.com —

Borregaard operates one of the world's most advanced and sustainable biorefineries.

Investment focus

Biotechnology, Chemical Engineering
Seed
Austria

Portfolio highlights

Kaffe Bueno — Kaffe Bueno upcycles coffee waste into active and functional ingredients for cosmetics, nutraceuticals and functional foods.
Alginor ASA — Alginor ASA is a marine biotech company committed to total utilisation of kelp through novel methods, making more than just alginates.
Lignovations — Lignovations develops high-performance ingredients from biomass. Accelerating the transition to a sustainable society.

We are peers amongst entrepreneurs helping the brave to build game-changing companies, just like we have done ourselves.

Investment focus

Software, SaaS, Artificial Intelligence
Seed, Series A, Series B
Germany, France, Sweden

Portfolio highlights

Codesphere — Codesphere is your Zeroconfig Cloud. No config - just code and run web apps from your browser. Team work on distributed full stack Typescript, and benefit from our automatic deployments, scaling, tests, and security / privacy audits. We optimize each and every detail to keep things simple for you. Codesphere is next level programming.
simplyblock — High-performance storage software designed for databases with low latency, high scalability and high IOPS. NVMe-optimized. Alternative SAN or EBS. Scalable Block Storage software. Simplyblock | Simply Block | Simplyblock Block Storage
Go Autonomous — Unlock advantages of Autonomous Commerce and experience heightened efficiency, reduced costs, and seamlessly interaction for both buyers and sellers.

venture capital

Investment focus

Software, Biotechnology, Information Technology
Seed, Series A, Series B
Hungary, South Korea, United States

Portfolio highlights

Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.

Join FoodTech focused investors looking to back impact-driven founders shaping our food system

Investment focus

Biotechnology, Food and Beverage, Food Processing
Seed, Pre-Seed, Series A
United States, Israel, United Kingdom

Portfolio highlights

twig bio — twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.
RAAAM Memory Technologies Ltd. — RAAAM provides a unique on-chip memory technology that offers the highest-density embedded memory solution in any standard CMOS process.RAAAM develops a high-density memory technology that allows for up to 50% higher on-chip memory density with no cost, complexity, or performance-penalty.
Cultivated Biosciences — Cultivated - Creamy, dairy-free indulgence

Financing for startups in Styria

Investment focus

Software, Audio, Travel
Seed, Grant, Funding Round
Austria

Portfolio highlights

teamazing — Unlock your team's full potential! Tailored workshops, tools & events for continuous team development. Analyze, build, and grow with teamazing!
Busfinder.com — Reisebus mieten mit Fahrer. Bus Angebote von Busunternehmen vergleichen und online buchen. Jetzt Bus buchen auf busfinder.com
Delphi Data Labs — Unlock your hidden market potential and use your data to its fullest potential. We offer everything from market analysis, data modelling and vizualization to system integration in your existing technical environment to super-charge your decision-making.

HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.

Investment focus

Biotechnology, Medical, Health Care
Series B, Funding Round, Series C
United States, Germany, Switzerland

Portfolio highlights

Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Mineralys Therapeutics — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101. MLS-101, licensed from MitsubishiTanabe Pharma Corporation, is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension.

Crédit Agricole CIB specialises in the businesses of capital markets and investment and corporate banking.

Investment focus

Energy, Solar, Renewable Energy
Debt Financing, Series A, Post-IPO Debt
France, United States, United Kingdom

Portfolio highlights

Chargeurs — Chargeurs specializes in developing and manufacturing surface protection, textile and technical products.
NEOM — THE LINE: THE FUTURE OF URBAN LIVING
Tipico Group — Tipico is the market provider of sports betting in Germany, with a strong position across other European markets as well. The company operates an innovative, digital multichannel offering with leading online and mobile portals, as well as more than 1,000 betting shops. As a premium brand, Tipico is able to offer a large range of bets whilecontinuing to uphold the highest standards in customer service and consumer protection. Tipico currently has more than 5,000 employees and operates in five countries.

RKP InnoInvest provides Investment capital and strategic services support progressive and dynamic start-ups and companies.

Investment focus

Biotechnology, Food and Beverage
Seed
Austria

Portfolio highlights

Hakuma — Belebender Boost aus der Natur | Premium Zutaten | Bio Matcha-Tee | 100% vegan
Econutri — Recycling CO2 for sustainable protein production

HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.

Investment focus

Software, Robotics, Artificial Intelligence
Seed, Series A, Pre-Seed
United States, France, United Kingdom

Portfolio highlights

Karman+ — Mining near Earth asteroids
Fuse Vectors — Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.
Orakl Oncology — Cultivated with love by the Orakl team.

Investing in the ReGeneration

Investment focus

Agriculture, Biotechnology, Farming
Seed, Series A, Series B
United States, Austria, United Kingdom

Portfolio highlights

Anthrogen — Anthrogen is a Biotechnology Research firm using bacteria and enzymes for reducing carbon in the air by transforming it into chemicals.
PACT — PACT designs Elegant materials produced in tune with the planet earth. It create revolutionary, sustainable biomaterials using the earth's resources, including collagen, herbal extracts, oils, and minerals.
Ulysses Ecosystem Engineering — Ulysses rewild the ocean and remove gigatons of carbon, contributing to global efforts to combat climate change and restore marine ecosystems.

Wir wollen unser wichtigstes Erbe erhalten. Eine lebenswerte Erde.

Investment focus

Farming, Renewable Energy, Solar
Seed, Grant, Pre-Seed
Switzerland, Germany, Austria

Portfolio highlights

Voltiris — Voltiris filters natural sunlight to transmit it to plants and recycle the "wasted" sunlight into green electricity.
Planeteers — We capture CO2 in water and unleash the potential of the oceans as the largest carbon sink on our planet.
Infrascreen — The transparent aluminium screen for extra energy-savings in greenhouses. Thanks to it's low-e coating, it saves up to 20% more than a regular energy-saving screen

The Austrian Federal Economic Chamber functions as the federal parent organization for the nine State Chambers and 110 trade associations for different industries within Austria's system of economy.

Investment focus

Software, Music, mHealth
Seed, Pre-Seed, Funding Round
Austria

Portfolio highlights

Music Traveler — Music Traveler is a rapidly growing aggregator and marketplace, bringing a highly fragmented B2B and B2BC environment to the sharing economy. Music Traveler centralises practice/rehearsal/performing spaces, equipment, and instruction for the performing arts – its mission is to promote the creation, appreciation and interest in music byy reducing barriers, facilitating new interactions.
The Apollinaire Group (TAG) — Intelligent supply chain management company.
SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.

ICL Startup Accelerator focuses on foodtech and crop nutrition startups, innovative products, and accelerates their market penetration

Investment focus

Biotechnology, Agriculture, Organic Food
Seed
Israel, Austria

Portfolio highlights

Lavie bio — Improve food quality, agricultural sustainability and productivity through the introduction of microbiome based ag-biological products.
Arkeon Biotechnologies — Arkeon converts CO2 into resources to power tomorrow's industries.

Santo Holding is a Zurich-based investment firm funding biotechnology, pharmaceutical, life sciences, and healthcare companies.

Investment focus

Biotechnology, Energy, Medical
Funding Round, Series B, Series C
Germany, Austria

Portfolio highlights

AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
SuppreMol — SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.
Efficient Energy — Efficient Energy GmbH is an innovative manufacturer and system supplier of environmentally friendly refrigeration technology, based in Feldkirchen near Munich, Germany. The company developed the Bluezero-technology, which uses water as a refrigerant and and thereby entirely avoids fluorinated refrigerants (HFCs). Efficient Energy helps itscustomers overcome the increasing regulatory challenges of refrigeration technology, and offers them long-term, sustainable solutions with its eChiller model range. The eChiller chilled water units are ideally suited for process cooling, machine cooling and the cooling of technical equipment and data centres and provide cooling capacities from 35 kW to 120 kW, depending on the model. With its outstanding cost efficiency and low CO2 footprint, companies benefit on many fronts. The pioneering technology has also been noticed by politics and the media, and has received multiple awards for the eChiller. These include among others the European Business Award for the Environment 2018/2019 from the European Comission and the Red Herring Europe Top 100 in 2020.

Axilium Holding

Investment focus

Life Science, Biotechnology, Semiconductor
Seed
Austria

Portfolio highlights

Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..

Air Street Capital invests in AI-first companies.

Investment focus

Artificial Intelligence, Machine Learning, Biotechnology
Seed, Series A, Pre-Seed
United States, United Kingdom, Canada

Portfolio highlights

Sereact — Discover the world's easiest pick and place automation solution. Significant cost savings, productive 24/7, deployment in one day and no training required.
Fern Labs — Deploying agents at the scale of real world problems
Odyssey — Odyssey operates as an AI start-up, provides hollywood-grade visual AI.

The Auxxo Female Catalyst Fund is a sector agnostic pre-seed and seed stage investors that backs female (co-)founded startups in Europe.

Investment focus

Software, Health Care, FinTech
Seed, Pre-Seed, Series A
Germany, United Kingdom, France

Portfolio highlights

BIOVOX — Mit Biokunststoff aus nachwachsenden Rohstoffen bis zu 85% CO2 einsparen. Hergestellt unter ISO 13485, biokompatibel nach ISO 10993.
Recyda GmbH — All-in-one Packaging Recyclability Management
Exakt Health — Exakt Health is the physio app for sports injuries. The Exakt Health app guides users through self-diagnosis for frequent sports injuries and then creates an individualized rehabilitation plan.

Matthias Wilrich is the VP Vehicles and Supply Chain at TIER Mobility.

Investment focus

E-Commerce, Delivery Service, Mobile Apps
Seed, Pre-Seed, Series A
Germany, Austria, Malaysia

Portfolio highlights

Lumaly — Lumaly is a browser extension that automatically tries out and uses all available voucher codes in the cart when shopping online.
MAYD — MAYD provides telepharmacy platform providing healthcare-related goods in a convenient way by delivering it to doorstep.
HELLO INSIDE — HELLO INSIDE is a scientific self care company empowering people to have data-driven conversations with their bodies. Unlock your best self.

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Investment focus

Biotechnology, Health Care, Medical
Series B, Private Equity, Funding Round
France, United States, Germany

Portfolio highlights

Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
Qualisteo — Qualisteo, a start-up company based in Nice specialised in smart grids company.
mylight150 — Mylight150 contributes to the creation of a society in which people generates own electricity to ensure self-sufficiency and long-term abundance.

4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.

Investment focus

Health Care, Biotechnology
Seed
Austria

Portfolio highlights

Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.

Investors by industry